A clinical and biochemical assessment of methotrexate in rheumatoid arthritis

[1]  J. Kremer,et al.  Methotrexate for Rheumatoid Arthritis , 1994 .

[2]  G. Bruyn,et al.  Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate? , 1992, Annals of the rheumatic diseases.

[3]  J. Kremer,et al.  Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. , 1992, Arthritis and rheumatism.

[4]  F. Wolfe,et al.  Are the results of controlled clinical trials and observational studies of second line therapy in rheumatoid arthritis valid and generalizable as measures of rheumatoid arthritis outcome: analysis of 122 studies. , 1991, The Journal of rheumatology.

[5]  J. Clough,et al.  Folate supplementation in methotrexate-treated rheumatoid arthritis patients. , 1991, Seminars in arthritis and rheumatism.

[6]  F. Wolfe,et al.  Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. , 1990, The Journal of rheumatology.

[7]  J. Korn,et al.  Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations. , 1985, The American journal of medicine.

[8]  M. Guttadauria,et al.  Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1985, Arthritis and rheumatism.

[9]  J. Esdaile,et al.  A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. , 1984, The Journal of rheumatology.

[10]  P. Leatham,et al.  A clinical and biochemical evaluation of Clozic, a novel disease modifying drug in rheumatoid arthritis. , 1983, Clinical and experimental rheumatology.

[11]  V. Wright,et al.  A human model screening system for the detection of specific antirheumatic activity. , 1982, Seminars in arthritis and rheumatism.

[12]  G. A. Bennett,et al.  1958 Revision of diagnostic criteria for rheumatoid arthritis. , 1959, Bulletin on the rheumatic diseases.

[13]  R. Gubner,et al.  THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: II. Effect of Aminopterin in Rheumatoid Arthritis and Psoriasis , 1951, The American journal of the medical sciences.